Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Bédard, Annabelle, 1986-
  • dc.contributor.author Basagaña Flores, Xavier
  • dc.contributor.author Antó i Boqué, Josep Maria
  • dc.contributor.author García Aymerich, Judith
  • dc.contributor.author MASK study group
  • dc.date.accessioned 2021-01-13T07:14:31Z
  • dc.date.available 2021-01-13T07:14:31Z
  • dc.date.issued 2020
  • dc.description.abstract Background: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. Methods: The Allergy Diary-MASK-air-mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. Results: 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. Conclusions: This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Bédard A, Basagaña X, Anto JM, Garcia-Aymerich J, Devillier P, Arnavielhe S et al. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study. Clin Transl Allergy. 2020; 10(1):62. DOI: 10.1186/s13601-020-00342-x
  • dc.identifier.doi http://dx.doi.org/10.1186/s13601-020-00342-x
  • dc.identifier.issn 2045-7022
  • dc.identifier.uri http://hdl.handle.net/10230/46150
  • dc.language.iso eng
  • dc.publisher BioMed Central
  • dc.relation.ispartof Clin Transl Allergy. 2020; 10(1):62
  • dc.rights © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data ma
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by/4.0/
  • dc.subject.keyword Allergic rhinitis
  • dc.subject.keyword Anti-histamines
  • dc.subject.keyword Corticosteroids
  • dc.subject.keyword ICT
  • dc.subject.keyword MASK
  • dc.subject.keyword Mobile health
  • dc.subject.keyword Treatment
  • dc.title Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Departament de Medicina i Ciències de la Vida)
Articles (Barcelona Institute for Global Health (ISGlobal) – Campus Mar)
Articles (Hospital del Mar Research Institute)